Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial Testing the Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan in Children With Newly Diagnosed DIPG

NCT02274987 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02274987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02274987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial Testing the Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan in Children With Newly Diagnosed DIPG
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
September 16, 2014
Completion date
February 24, 2019
Enrollment
38 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse intrinsic pontine glioma (dipg)